A: Developed using Allergan’s proprietary Vycross technology, JUVÉDERM® VOLBELLA®with lidocaine is formulated with an innovative combination of low and high molecular weight technology, which improves the cross-linking efficiency of HA chains. This more effective cross-linking allows for a lower concentration of HA to be used, which results in less swelling. The Vycross technology delivers an ultra-smooth gel, which results in a natural look and feel, as well as improved duration.
This unique technology allows the product to absorb less water, resulting in considerably reduced swelling compared to more traditional fillers. Not only is there less downtime, the treatment itself is made as pain free as possible by the built-in lidocaine anaesthetic. Results are commonly seen to last up to twelve months.